Isa Pharmaceuticals – Immune System Activation

  • nl
  • fr
  • de
  • Home
  • Company
    • Company Milestones
    • Strategy
    • Management
    • Supervisory Board
    • Advisory Board
  • Pipeline
    • Pipeline Chart
    • Pipeline Overview
  • Clinical Studies
  • Technology
    • SLP® Concept
    • Publications
    • Technology Overview
  • News & Events
    • News Archive
    • Upcoming Events
  • Job Openings
  • Contact
    • Imprint / Disclaimer

Immunotherapeutics against cancer and infectious diseases

ISA Pharmaceuticals B.V. is developing rationally designed, fully synthetic immunotherapeutics against cancer and persistent viral infections.

Read more

News

  • February 15, 2018

    ISA Pharmaceuticals and Scancell enter collaboration agreement for the manufacturing, development and commercialisation of Modi-1 / AMPLIVANT® combination

  • January 3, 2018

    ISA Pharmaceuticals to Present at the Biotech Showcase™ Annual Conference 2018

Events

  • May 14 – 16, 2018

    Bio€quity Europe 2018

  • May 15 – 17, 2018

    CIMT Meeting

Latest Publications

  • September 5, 2016
    Cancer Research / Science Translational Medicine

    Cancer Research / Science Translational Medicine

More news
More events
More publications
Loading Quotes...
© ISA Pharmaceuticals B.V. all rights reserved
  • Contact
  • Sitemap
  • Imprint / Disclaimer